NovoCure (NVCR) Stock Forecast & Price Prediction

Estimation of the future price movement of NovoCure stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $13.05

Concensus $136.50

Low $99.00

Median $123.50

High $200.00

Based on analysts projections #NVCR is expected to experience a positive growth trajectory over the next year.

The current average NVCR price target, as estimated by these analysts, is $136.50.

The predictions for the future NVCR stock price range from a low of $99.00 to a high of $200.00, highlighting the variability of market expectations for NVCR.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

NVCR stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
J.P. Morgan January 6, 2023 Buy 99.00 109.04
Wells Fargo January 6, 2023 Buy 107.00 118.81
Emily Bodnar
H.C. Wainwright
January 5, 2023 Buy 140.00 107.44
Wells Fargo November 29, 2022 Buy 89.00 70.06
Emily Bodnar
H.C. Wainwright
May 16, 2022 Buy 115.00 65.24
Jason Wittes
Loop Capital Markets
February 8, 2022 Buy 200.00 75.30

NovoCure (NVCR) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if NovoCure is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.


Financial Scores

Updated on: 06/12/2023

Altman Z-Score: 0.6

Piotroski Score: 1.0

ESG Score

Updated on: 06/12/2023

Environmental: 80.3

Social: 76.0

Governance: 73.1

Financial Health

Updated on: 06/12/2023

DCF: Strong Buy

ROE: Neutral

ROA: Neutral

Debt to equity ratio: Buy

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Buy

NVCR Discounted Cash Flow

Updated on: 06/12/2023

Discounted Cash Flow Value

Current Price

NVCR Revenues by Segment

Updated on: 06/12/2023

No available data

Revenue from Contract with Customer, Excluding Assessed Tax

NVCR Revenues by Region

Updated on: 06/12/2023

Other EMEA

NVCR Notes Due

Updated on: 06/12/2023


There are no data to display

NovoCure (NVCR) Social Sentiments

Monitoring bullish and bearish sentiments towards NovoCure on Twitter and Stocktwits could help to forecast an upward or downward trend in NovoCure stock price.

No social results for NVCR

Analyzing the Stock Forecast of NovoCure Ltd. (NVCR): A Promising Future

NovoCure Ltd. (NVCR) is a medical technology company that operates in the Medical Instruments & Supplies sector. Since its founding in 2000, NovoCure has been focused on developing innovative therapy solutions for patients suffering from cancer. The company's flagship product is Optune, a non-invasive device that uses electric fields to disrupt cancer cell division and growth. Stock Forecast: When it... Read more

NovoCure: A Promising Stock Prediction in the Medical Instruments & Supplies Sector Amidst Cancer Treatment Innovations

The Medical Instruments & Supplies sector is a vital component of the healthcare industry, providing essential tools and equipment that are required for diagnosis, treatment, and monitoring patients. The demand for these medical instruments and supplies remains steady due to an aging population that requires more medical care than ever before. As long as people continue to require medical attention,... Read more